Obesity pill data signal competition and hit drugmaker shares
Obesity pill data released by Viking Therapeutics Inc and AstraZeneca Plc at a big conference foreshadowed an increasingly ...
Viking Therapeutics participates in a conference call with JPMorgan
Conference call with CEO Dr. Lian and CFO Zante to be held on November 5 at 11:30 am hosted by JPMorgan. Webcast Link Published first on ...
USA Today14h
Houston Texans trade RB Cam Akers to Minnesota Vikings
Running back Cam Akers is returning to Minnesota. The Houston Texans have agreed to trade Akers to the Vikings, the Vikings announced Tuesday night. Minnesota will also get a conditional 2026 ...
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...
PicoCELA Seeks High Valuation U.S. IPO On Worsening Operating Results
PicoCELA Inc. has filed to raise $10M in a U.S. IPO to fund inventory and product R&D. Click here for more on PCLA stock, and why my outlook on the IPO is to sell.
Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference
WATERTOWN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative ...
Is Viking Therepautics a Buy Now?
Shares of Viking Therapeutics (NASDAQ: VKTX) fell on Monday, Nov. 4, despite some encouraging new data. Over the weekend, the ...